Ludwig Center at MSK
Ludwig Institute for Cancer Research
United States of America
I am a board-certified nuclear medicine physician who cares for patients using radiotargeted therapy, particularly for people with thyroid cancer. My clinical interests focus on the use of positron emission tomography (PET) for diagnostic and molecular imaging, as well as targeted therapy and theranostics. At Memorial Sloan Kettering, I use radioantibodies and PET in oncologic imaging, both for basic research and patient management.
Nuclear medicine, dignostics, molecular imaging, cancer detection, PET scan
Schoder, Heiko, et al. "Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion." Radiology 231.1 (2004): 65-72.
Patronas, Nicholas J., et al. "Prediction of survival in glioma patients by means of positron emission tomography." Journal of neurosurgery 62.6 (1985): 816-822.
Kelloff, Gary J., et al. "Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development." Clinical Cancer Research 11.8 (2005): 2785-2808.